305 related articles for article (PubMed ID: 29397189)
1. Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery: A Randomized, Placebo-Controlled, Phase III Trial.
Donnenfeld E; Holland E
Ophthalmology; 2018 Jun; 125(6):799-806. PubMed ID: 29397189
[TBL] [Abstract][Full Text] [Related]
2. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
Donnenfeld ED; Solomon KD; Matossian C
J Cataract Refract Surg; 2018 Oct; 44(10):1236-1246. PubMed ID: 30139638
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.
Tan DT; Chee SP; Lim L; Theng J; Van Ede M
Ophthalmology; 2001 Dec; 108(12):2172-81. PubMed ID: 11733254
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
5. Phase II results of an intraocular steroid delivery system for cataract surgery.
Chang DF; Garcia IH; Hunkeler JD; Minas T
Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery.
Walters T; Endl M; Elmer TR; Levenson J; Majmudar P; Masket S
J Cataract Refract Surg; 2015 Oct; 41(10):2049-59. PubMed ID: 26703279
[TBL] [Abstract][Full Text] [Related]
8. Two clinical trials of an intraocular steroid delivery system for cataract surgery.
Chang DF; Wong V
Trans Am Ophthalmol Soc; 1999; 97():261-74; discussion 274-9. PubMed ID: 10703128
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.
Gungor SG; Bulam B; Akman A; Colak M
Indian J Ophthalmol; 2014 Aug; 62(8):861-4. PubMed ID: 25230962
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes.
Dixit NV; Shah SK; Vasavada V; Vasavada VA; Praveen MR; Vasavada AR; Trivedi RH
J Cataract Refract Surg; 2010 Sep; 36(9):1494-8. PubMed ID: 20692560
[TBL] [Abstract][Full Text] [Related]
11. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
Walters TR; Goldberg DF; Peace JH; Gow JA;
Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery.
Kiernan DF
BMJ Open Ophthalmol; 2020; 5(1):e000491. PubMed ID: 32426525
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy.
Wang B; Dong N; Xu B; Liu J; Xiao L
J Cataract Refract Surg; 2013 Nov; 39(11):1691-7. PubMed ID: 24160382
[TBL] [Abstract][Full Text] [Related]
14. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
[TBL] [Abstract][Full Text] [Related]
15. Comparison of preservative-free bupivacaine vs. lidocaine for intracameral anesthesia: a randomized clinical trial and in vitro analysis.
Anderson NJ; Nath R; Anderson CJ; Edelhauser HF
Am J Ophthalmol; 1999 Apr; 127(4):393-402. PubMed ID: 10218691
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.
Cohen AE; Assang C; Patane MA; From S; Korenfeld M;
Ophthalmology; 2012 Jan; 119(1):66-73. PubMed ID: 22115712
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
[TBL] [Abstract][Full Text] [Related]
18. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.
Dieleman M; Wubbels RJ; van Kooten-Noordzij M; de Waard PW
J Cataract Refract Surg; 2011 Sep; 37(9):1589-97. PubMed ID: 21855759
[TBL] [Abstract][Full Text] [Related]
19. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery.
Laurell CG; Zetterström C
Br J Ophthalmol; 2002 Dec; 86(12):1380-4. PubMed ID: 12446370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
